IGC Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGC Pharma and other ETFs, options, and stocks.About IGC
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development.
CEORam Mukunda
CEORam Mukunda
Employees70
Employees70
HeadquartersPotomac, Maryland
HeadquartersPotomac, Maryland
Founded2005
Founded2005
Employees70
Employees70
IGC Key Statistics
Market cap29.73M
Market cap29.73M
Price-Earnings ratio-4.11
Price-Earnings ratio-4.11
Dividend yield—
Dividend yield—
Average volume391.24K
Average volume391.24K
High today$0.3387
High today$0.3387
Low today$0.3165
Low today$0.3165
Open price$0.3209
Open price$0.3209
Volume323.28K
Volume323.28K
52 Week high$0.4985
52 Week high$0.4985
52 Week low$0.2525
52 Week low$0.2525
Stock Snapshot
With a market cap of 29.73M, IGC Pharma(IGC) trades at $0.32. The stock has a price-to-earnings ratio of -4.11.
On 2025-11-27, IGC Pharma(IGC) stock moved within a range of $0.32 to $0.34. With shares now at $0.32, the stock is trading +1.5% above its intraday low and -5.2% below the session's peak.
Trading volume for IGC Pharma(IGC) stock has reached 323.28K, versus its average volume of 391.24K.
The stock's 52-week range extends from a low of $0.25 to a high of $0.50.
The stock's 52-week range extends from a low of $0.25 to a high of $0.50.
People also own
Based on the portfolios of people who own IGC. This list is generated using Robinhood data, and it’s not a recommendation.